跳至主要内容
临床试验/NL-OMON48584
NL-OMON48584招募中不适用

Clinical impact of dedicated MR staging of ovarian cancer patients - MRStagingOC

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 270 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
270

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients with advanced stage (FIGO stage III or IV) ovarian cancer scheduled for primary or interval cytoreductive surgery
  • - Age >18 years
  • - Written informed consent

排除标准

  • Patients with contraindications for MRI:
  • - Patients who have a heart pacemaker may not have an MRI scan
  • - Patients who have a metallic foreign body (metal sliver) in their body
  • - Patients with severe claustrophobia
  • - Contrast allergy for MRI contrast agent Gadolinium (extremely rare)
  • - Ineligibility to receive gadofosveset contrast (history of contrast allergy, impaired kidney function with a Glomerular Filtration Rate <30 ml/min/1.73m2)
  • - Ineligibility to receive Buscopan
  • - Allergy for pineapple juice and blueberry juice.
  • Patients with contraindications for CRS
  • - WHO performance status 3 or higher

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验